Grant: Discovery Grants Program - Individual
Institut national de la recherche scientifique
$25,000.00
Placental melatonin system: functions and mechanisms of action
FY 2010-11
Summary
The human placenta acts as a central regulator of maternal and fetal physiology. Although the role of melatonin on fetal development has been the subject of a number of studies, data on its role in placental physiology are scarce. We have demonstrated that human placenta expresses melatonin receptors. We have also shown the presence and activity of the enzymes responsible for melatonin synthesis and placental melatonin production in placental trophoblast cells. These results strongly suggest an important paracrine, autocrine and/or intracrine role for melatonin and its receptors in placental function and development and, consequently, in pregnancy and fetal health. However, the role of melatonin in placental function and development is still obscure. Thus, our research program aims to elucidate the role and cellular mechanism of melatonin and its receptors in placental endocrine function as well as on trophoblast development. That is, to better understand the role of this trypthophan-derived hormone and its receptors in placental health, and by consequence in pregnancy well-being and fetal development and to develop a new human cellular model to study the regulation and function of melatonin and its receptors on normal and abnormal cellular processes and open the way for new preventive and therapeutic approaches in these areas for variety of disorders including obstetric complications, depression, cancer, and neurodegenerative diseases.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
262011-2009
Name nom
Vaillancourt, Cathy
Department département
INRS-Institut Armand-Frappier
Organization id
56
Institution établissement
Institut national de la recherche scientifique
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2009
Award amount
25000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
2
Nb partie
5
Application title
Placental melatonin system: functions and mechanisms of action
Keyword
NSERC
Application summary
The human placenta acts as a central regulator of maternal and fetal physiology. Although the role of melatonin on fetal development has been the subject of a number of studies, data on its role in placental physiology are scarce. We have demonstrated that human placenta expresses melatonin receptors. We have also shown the presence and activity of the enzymes responsible for melatonin synthesis and placental melatonin production in placental trophoblast cells. These results strongly suggest an important paracrine, autocrine and/or intracrine role for melatonin and its receptors in placental function and development and, consequently, in pregnancy and fetal health. However, the role of melatonin in placental function and development is still obscure. Thus, our research program aims to elucidate the role and cellular mechanism of melatonin and its receptors in placental endocrine function as well as on trophoblast development. That is, to better understand the role of this trypthophan-derived hormone and its receptors in placental health, and by consequence in pregnancy well-being and fetal development and to develop a new human cellular model to study the regulation and function of melatonin and its receptors on normal and abnormal cellular processes and open the way for new preventive and therapeutic approaches in these areas for variety of disorders including obstetric complications, depression, cancer, and neurodegenerative diseases.